REMIBRUTINIB

1354 reported adverse events

Drug classes: Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking REMIBRUTINIB:

# Side effect Count
0 URTICARIA 186
1 PETECHIAE 185
2 DRUG INEFFECTIVE 148
3 CONTUSION 130
4 PRURITUS 105
5 HEADACHE 77
6 HEAVY MENSTRUAL BLEEDING 59
7 NAUSEA 58
8 OFF LABEL USE 57
9 CONDITION AGGRAVATED 53
See all common reactions for REMIBRUTINIB

REMIBRUTINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PLATELET DISTRIBUTION WIDTH DECREASED 3 0.0638
1 MENTAL DISORDER DUE TO A GENERAL MEDICAL CONDITION 15 0.0479
2 CHRONIC SPONTANEOUS URTICARIA 44 0.0379
3 ANTI-THYROID ANTIBODY INCREASED 3 0.0238
4 PETECHIAE 185 0.0177
5 HYPOAESTHESIA TEETH 2 0.0156
6 EOSINOPHIL PERCENTAGE DECREASED 3 0.0151
7 URTICARIA CHRONIC 4 0.0071
8 HEAVY MENSTRUAL BLEEDING 59 0.0066
9 IDIOPATHIC URTICARIA 7 0.0065
See all enriched reactions for REMIBRUTINIB